The study showed animals that had been injected with Hoodia had a significant decrease in appetite, leading to the conclusion that Hoodia can effectively act as an appetite suppressant and weight loss aid. With these results, scientists conducted further studies to identify and extract the molecule responsible for suppressing appetite, naming the molecule P57 and patenting the extraction formula. Subsequently, the patent was leased to British pharmaceutical Phytopharm. Further studies were conducted (including human trials) to reaffirm that Hoodia can be safely used for dieting and slimming. Once the results were made public, Pfizer (a large pharmaceutical company) became interested in developing a weight loss tablet in the form of a Hoodia diet pill. However, the cost to manufacture the extract was not viable, and the strength of the extract produced varying results. Pfizer dropped out of the partnership and Unilever (another pharmaceutical) is continuing development of the Hoodia weight loss pills. To date, US and Canada Hoodia products from these companies are not yet available and are still in the process of development.
|